Effectiveness of Mepolizumab in Patients with OCS-Dependent Severe Asthma: A Real-World Study
In patients with severe asthma and OCS dependence from the countries studied, mepolizumab reduced OCS use and dose, asthma exacerbations, and improved symptom control.
Authors
- P.C. Kathuria (ORCID: https://orcid.org/0000-0002-6053-5192)
- Riyad Al‐Lehebi (ORCID: https://orcid.org/0000-0002-3232-6668)
- Tayseer Ibrahim (ORCID: https://orcid.org/0000-0003-0577-610X)
- Saeed Noibi (ORCID: https://orcid.org/0009-0002-4075-7182)
- Nasser Al Busaidi
- Sevim Bavbek (ORCID: https://orcid.org/0000-0002-7884-0830)
- Gur Levy (ORCID: https://orcid.org/0000-0002-5115-921X)
- Mona Al‐Ahmad (ORCID: https://orcid.org/0000-0003-2950-5363)
- Patricia Fernández (ORCID: https://orcid.org/0000-0002-1702-4637)
- Bassam Mahboub (ORCID: https://orcid.org/0000-0002-6089-438X)
- Seema Haider
- Hala Samaha
Institutions
- Dubai Health Authority (AE)
- Alfaisal University (SA)
- Ankara University (TR)
- Oasis Hospital (AE)
- Rashid Hospital (AE)
- King Fahd Medical City (SA)
- Kuwait University (KW)
- Colegio Médico de Chile (CL)
- Health Outcomes Solutions (United States) (US)
- ENT and Allergy (US)
- Ankara Spine Center (TR)
- Ministry of Health (KW)
- Royal Hospital (OM)
- Health Economics and Outcomes Research (United Kingdom) (GB)
- Hamad Medical Corporation (QA)
Publication Details
- Journal
- Advances in Therapy
- Published
- 2025-08-29
- DOI
- https://doi.org/10.1007/s12325-025-03338-w
- Primary Topic
- Asthma and respiratory diseases
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Ankara Universitesi
- Ege Üniversitesi
- Koç Üniversitesi